BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37752678)

  • 61. The integration of BRCA testing into oncology clinics.
    Percival N; George A; Gyertson J; Hamill M; Fernandes A; Davies E; Rahman N; Banerjee S
    Br J Nurs; 2016 Jun; 25(12):690-4. PubMed ID: 27345073
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The "Begin Exploring Fertility Options, Risks and Expectations" (BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients.
    Speller B; Metcalfe K; Kennedy ED; Facey M; Greenblatt E; Scheer AS; Warner E; Joy AA; Wright FC; Baxter NN
    BMC Med Inform Decis Mak; 2019 Oct; 19(1):203. PubMed ID: 31660965
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Information-seeking behaviour and psycho-social interactions during the genetic testing process.
    Cypowyj C; Eisinger F; Morin M; Mogoutov A; Sobol H; Julian-Reynier C
    Community Genet; 2003; 6(4):224-34. PubMed ID: 15331868
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Strategies for distributing cancer screening decision aids in primary care.
    Brackett C; Kearing S; Cochran N; Tosteson AN; Blair Brooks W
    Patient Educ Couns; 2010 Feb; 78(2):166-8. PubMed ID: 19665338
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
    Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK
    J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.
    Powell CB; Laurent C; Ciaravino G; Garcia C; Han L; Hoodfar E; Karlea A; Kobelka C; Lee J; Littell RD; Roh J; Vay A; Kushi LH
    Gynecol Oncol; 2020 Oct; 159(1):221-228. PubMed ID: 32778409
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial.
    Kautz-Freimuth S; Redaèlli M; Shukri A; Kentenich H; Simic D; Mildenberger V; Schmutzler R; Rhiem K; Stock S
    BMC Med Inform Decis Mak; 2023 Oct; 23(1):223. PubMed ID: 37845719
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effects of culturally targeted patient decision aids on medical consultation preparation for Hispanic women in the U.S.: Results from four randomized experiments.
    Alden DL; Friend J; Fraenkel L; Jibaja-Weiss M
    Soc Sci Med; 2018 Sep; 212():17-25. PubMed ID: 29990671
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development and Testing of an Adjuvant Radiotherapy Decision Aid for Older Women Diagnosed with Stage I Breast Cancer: A Pilot Study.
    Neve M; Henry-Noel N; Mehta R; Trudeau M; Menjak I; Szumacher E
    Cureus; 2020 Apr; 12(4):e7690. PubMed ID: 32440378
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk.
    Wakefield CE; Meiser B; Homewood J; Peate M; Kirk J; Warner B; Lobb E; Gaff C; Tucker K
    J Genet Couns; 2007 Jun; 16(3):325-39. PubMed ID: 17318456
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches.
    Tone AA; McCuaig JM; Ricker N; Boghosian T; Romagnuolo T; Stickle N; Virtanen C; Zhang T; Kim RH; Ferguson SE; May T; Laframboise S; Armel S; Demsky R; Volenik A; Stuart-McEwan T; Shaw P; Oza A; Kamel-Reid S; Stockley T; Bernardini MQ
    Gynecol Oncol; 2021 Jul; 162(1):97-106. PubMed ID: 33858678
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of a Mammography Screening Decision Aid for Women 75 Years and Older: A Cluster Randomized Clinical Trial.
    Schonberg MA; Kistler CE; Pinheiro A; Jacobson AR; Aliberti GM; Karamourtopoulos M; Hayes M; Neville BA; Lewis CL; Wee CC; Fagerlin A; Nekhlyudov L; Marcantonio ER; Hamel MB; Davis RB
    JAMA Intern Med; 2020 Jun; 180(6):831-842. PubMed ID: 32310288
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development of a Decision Aid for Patients With Advanced Heart Failure Considering a Destination Therapy Left Ventricular Assist Device.
    Thompson JS; Matlock DD; McIlvennan CK; Jenkins AR; Allen LA
    JACC Heart Fail; 2015 Dec; 3(12):965-76. PubMed ID: 26671675
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Internet Versus DVD Decision Aids for Hip and Knee Osteoarthritis.
    Allen KD; Sanders LL; Olsen MK; Bowlby L; Katz JN; Mather RC; Williams JW
    Musculoskeletal Care; 2016 Jun; 14(2):87-97. PubMed ID: 26220784
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current Practice.
    Czekalski MA; Huziak RC; Durst AL; Taylor S; Mai PL
    JCO Precis Oncol; 2022 Jan; 6():e2100409. PubMed ID: 35025618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.
    Gray SW; O'Grady C; Karp L; Smith D; Schwartz JS; Hornik RC; Armstrong K
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1303-11. PubMed ID: 19318436
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oncoplastic breast-conserving surgery for women with primary breast cancer.
    Nanda A; Hu J; Hodgkinson S; Ali S; Rainsbury R; Roy PG
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013658. PubMed ID: 34713449
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development and evaluation of a decision aid on mammography screening for women 75 years and older.
    Schonberg MA; Hamel MB; Davis RB; Griggs MC; Wee CC; Fagerlin A; Marcantonio ER
    JAMA Intern Med; 2014 Mar; 174(3):417-24. PubMed ID: 24378846
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Investigating harms of testing for ovarian cancer - psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study.
    Kwong FL; Kristunas C; Davenport C; Aggarwal R; Deeks J; Mallett S; Kehoe S; Timmerman D; Bourne T; Stobart H; Neal R; Menon U; Gentry-Maharaj A; Sturdy L; Ottridge R; Sundar S;
    BJOG; 2024 Mar; ():. PubMed ID: 38556698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.